RxUtility Launches Personalized AI Companion Mimi™ to Compare Every Drug Price as Affordability Crisis Grows

Why It Matters

By delivering transparent, real‑time pricing, Mimi can improve medication adherence and lower out‑of‑pocket spending, addressing a major driver of health‑care cost concerns for consumers and payers alike.

Key Takeaways

• Free beta of Mimi offers AI-driven, pharmacy‑wide price comparison
• Targets 98 million abandoned prescriptions caused by cost surprises
• Integrates via API or white‑label for providers, payers, employers
• Enhances adherence by giving consumers confidence in their medication costs

Pulse Analysis

The United States faces a prescription‑drug affordability crisis, with roughly 98 million prescriptions abandoned each year because patients encounter unexpected costs. Surveys show that 43% of adults have skipped doses due to price uncertainty, and six in ten Americans express worry about medication expenses. This lack of transparency fuels non‑adherence, higher downstream health costs, and a growing demand for tools that can demystify pricing at the point of care.

Enter Mimi, RxUtility’s AI‑driven companion that leverages the company’s proprietary affordability database covering every pharmacy and discount program nationwide. By asking simple conversational prompts—drug name, dosage, insurance details—Mimi instantly aggregates insurance estimates, copay coupons, cash discounts, and geo‑located pharmacy prices. The result is a single, personalized price list that users can compare in real time. Built as an API‑first, white‑label solution, Mimi can be embedded into provider portals, employer health platforms, or payer apps, extending its reach beyond a consumer‑only interface.

For the broader health‑tech ecosystem, Mimi represents a scalable pathway to improve medication adherence and reduce out‑of‑pocket burdens. Organizations that integrate the tool can expect higher prescription fill rates, lower administrative overhead, and stronger member satisfaction. As payers and employers intensify focus on value‑based care, transparent pricing engines like Mimi are likely to become standard components of digital health stacks, driving both clinical outcomes and cost containment across the industry.